Public health stakeholders urge gov't to sustain Rare Disease Act | Inquirer News

Public health stakeholders urge gov’t to sustain Rare Disease Act

/ 10:09 PM August 25, 2022

Public health stakeholders urge gov't to sustain Rare Disease Law implementation

Heart disease x-ray | STOCK IMAGE

MANILA, Philippines —  Aiming to ensure its envisioned implementation and consistent funding, public health stakeholders called on the government to sustain the Rare Disease Act of the Philippines.

In a recent statement, Stratbase ADR Institute President Professor Victorio Andres Manhit cited the evident inadequacy in the implementation of the law.

Article continues after this advertisement

“There is an evident disproportion in the availability of treatment and resources, and this inequality is being aggravated by the COVID-19 pandemic,” Manhit said.

FEATURED STORIES

Following the Congress’ budget allocation, Manhit stressed that it is time for stakeholders to address the concerns in its implementation.

“Now that Congress has earmarked P104.9 million for this after six long years, it is time all stakeholders worked to address the deeply complex issue of inequality through good governance, political reforms, social investments and multi-sector efforts,” Manhit added.

Article continues after this advertisement

Several representatives of stakeholder groups including Dr. Razel Nikka Hao, Dr. Eva Maria Cutiongco-dela Paz, Ms. Daisy Sembrano, Durhane Wong-Rieger Ph.D., Ms. Cynthia Magdaraog, and Dr. Carmencita Padilla also aired they insights on the importance of the law.

Article continues after this advertisement

“We are trying to be as inclusive as possible despite some of the limitations in the law,” Padilla said.

Article continues after this advertisement

Furthermore, Padilla emphasized that a whole of society approach is needed in addressing the concerns.

On the other hand, Senator Sonny Angara, Chair of the Senate Committee for Finance, recognized the challenges in funding due to the pandemic.

Article continues after this advertisement

Angara added that the appropriation is hardly enough for providing treatment and funding research into new rare diseases.

Despite this, the senator has reiterated the commitment of the legislative body in supporting the cause, mentioning that the private sector should be encouraged – incentivized – and should partner with the government in making progress to fight against rare diseases.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The Rare Disease Act was passed in 2016 as a means to address the needs of persons with rare diseases and to increase their rate of survival. — Christian Paul Dela Cruz, Inquirer.net trainee

RELATED STORIES:

Senate bill makes headway to help Filipinos with rare diseases

Filipinos with rare ailments seek gov’t help

JMS

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, rare disease, Sonny Angara

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.